Invention Grant
- Patent Title: Recombinant cytotoxic T-lymphocyte-associated protein 4 (CTLA4)
-
Application No.: US14389013Application Date: 2013-02-28
-
Publication No.: US09758566B2Publication Date: 2017-09-12
- Inventor: Zhirui Wang , David H. Sachs , Christene A. Huang
- Applicant: The General Hospital Corporation
- Applicant Address: US MA Boston
- Assignee: The General Hospital Corporation
- Current Assignee: The General Hospital Corporation
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2013/028196 WO 20130228
- International Announcement: WO2013/148049 WO 20131003
- Main IPC: C07K14/705
- IPC: C07K14/705 ; A61K38/00 ; C07K14/21 ; C07K14/34
Abstract:
This invention relates to recombinant CTLA-4 proteins, e.g., soluble CTLA-4 or CTLA-4 fusion toxins, and methods for making and using them.
Public/Granted literature
- US20150118260A1 Recombinant Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Public/Granted day:2015-04-30
Information query
